Board of Directors

Marianne Dicander Alexandersson
Marianne Dicander Alexandersson
Chairman since 2022 and Board Member since 2017

Born: 1959.

Marianne was previously CEO of Kronans Droghandel AB, Sjätte AP-fonden and Global Health Partner AB and deputy CEO of Apoteket. She holds an M.Sc. in Chemical Engineering from Chalmers Technical College in Gothenburg.

Other Assignments: Marianne serves as chairman of Sahlgrenska Science Park AB, board member and CEO of MDA Management AB, board member of Recipharm AB (publ), Enzymatica AB (publ), Praktikertjänst Aktiebolag, Camurus AB, AdderaCare AB and Xperentia AB.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: Yes.
Share Holding in Promore Pharma: No current holding.

Göran Linder
Göran Linder
Board Member since 2015

Born: 1962.

Göran serves as Senior Executive in several investment companies. He was previously board member in among others Transic AB, Jensen Devices AB, Airgrinder AB and Lamera AB. Göran holds an M.Sc. from the KTH Royal Institute of Technology in Stockholm.

Other Assignments: CEO and board member in Corespring New Technology AB, Corespring Invest AB and Corespring Finans AB. Board member in Powercell Sweden AB (publ), Powercell Warrants One AB, Nilsson Special Vehicles Aktiebolag (publ), Pergamum AB, Minesto AB (publ), Minesto Warrants One AB, Crunchfish AB (publ) M&J by Malin & Johanna AB and QCG Sweden AB. He is a deputy board member in Heliospectra AB (publ) och Corpower Ocean AB.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: No.
Share Holding in Promore Pharma: Representing Corespring New Technology AB owning 22,710,730 shares in the Company.

Kerstin Valinder Strinnholm
Kerstin Valinder Strinnholm
Board Member since 2019

Born: 1960.

Kerstin has been responsible for business development and business strategy at Nycomed (now Takeda) and previously held leading positions in marketing and business development at Astra and AstraZeneca. She holds a degree from the journalism program at the University of Gothenburg.

Other Assignments: Board member of Immedica Pharma AB, Moberg Pharma AB (publ), Bioservo Technologies AB (publ), Camurus AB (publ), KVS Invest AB and Cavastor AB.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: Yes.
Share Holding in Promore Pharma: No current holding.

Hans-Peter Ostler
Hans-Peter Ostler

Board Member since 2021

Born: 1971

Hans-Peter Ostler works as a wealth advisor at Söderberg & Partners in Gothenburg, one of the leading advisors and distributors of insurance and financial products in Sweden. Hans-Peter Ostler possesses close to three decades of experience in investment banking and private banking.

Other ongoing assignments: Hans-Peter Ostler is board director in Alligator Biosciences AB, Inorbit Therapeutics AB, Oblique Therapeutics AB, and S.P. HMSO Göteborg AB as well as serving as a deputy board member of O Mgmt AB.
Independent in relation to Promore Pharma and its senior executives: Yes
Independent in relation to major shareholders: Yes
Share holding in Promore Pharma: 646,010 shares.

Candice (Yujin) Jung
Board member since 2022

Born: 1991.
Candice serves as head of PharmaResearch USA. She has a Doctor of Pharmacy (PharmD) degree from Northeastern University, Boston, USA. She has previously held positions in marketing and business development including within Johnson & Johnson and the South Korean pharmaceutical company Daewoong Pharmaceutical.

Other Assignments: Candice holds no other board assignments.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders: No.
Share Holding in Promore Pharma: Representing PharmaResearch Co. Ltd and PharmaResearch USA owning 7,468,132 shares in the Company.

Holdings as of March 29, 2019.